Trans-Pacific Technology Fund
Overview
Trans-Pacific Technology Fund (TPTF) is a technology-driven venture capital firm investing in innovative companies shaping the future of global business. TPTF focuses on disruptive, platform technologies across sectors such as advanced materials, health/life sciences, ICT, IoT, and robotics/automation. With a multi-stage investment strategy, TPTF supports companies from early to expansion/late stages, leveraging its extensive international resources and deep domain expertise to actively work with the leadership of its portfolio companies worldwide. TPTF's investment approach emphasizes the belief that the cornerstone of every great company is great people. The firm considers itself a committed partner, providing capital and supporting entrepreneurs through its extensive international resources, deep domain expertise, and passion to build great companies. TPTF's global investment scope spans across Asia, North America, and Europe, seeking to invest in companies that are at the forefront of technological innovation. The firm's portfolio includes companies such as Apexigen, a clinical-stage biopharmaceutical company developing antibody therapeutics for cancer treatment; Finch Therapeutics, a late clinical-stage company focused on therapeutics leveraging its Full-Spectrum Microbiota platform; and Quanergy Systems Inc., a provider of LiDAR sensors and perception software for real-time 3D data capture and processing. TPTF's diverse portfolio reflects its commitment to investing in companies that are driving technological advancements across various industries and regions.
Investment Focus
- Innovative companies in advanced materials, health/life sciences, ICT, IoT, and robotics/automation sectors
- Early to expansion/late stage companies
- Global investment scope including Asia, North America, and Europe
Portfolio Companies
Reach Trans-Pacific Technology Fund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Trans-Pacific Technology Fund
What sectors does Trans-Pacific Technology Fund invest in?
Trans-Pacific Technology Fund invests in FinTech, Artificial Intelligence, ICT, IoT, Advanced Materials and Health/Life Sciences, and is based in Taipei, Taiwan. Trans-Pacific Technology Fund is listed as a venture capital in the ConnectSafely investor database.
What stage does Trans-Pacific Technology Fund invest at?
Trans-Pacific Technology Fund backs companies at Early Stage and Late Stage, writing cheques of 1M - 4M.
Which regions does Trans-Pacific Technology Fund invest in?
Trans-Pacific Technology Fund invests across United States, United Kingdom, Germany, Japan, Australia and Singapore.
What companies has Trans-Pacific Technology Fund invested in?
Trans-Pacific Technology Fund's portfolio includes Kata.ai, Zymergen, Apexigen, Finch Therapeutics, Quanergy Systems Inc., CleanWave Technologies, Googol Technology and Heal.
How do I contact Trans-Pacific Technology Fund?
Trans-Pacific Technology Fund's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
